The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
Terry Golombick, Terry DiamondDepartment of Endocrinology, St George Hospital, Kogarah, AustraliaAbstract: Plasma cell dyscrasias, most commonly associated with paraproteinemia, are a diverse group of diseases. Monoclonal gammopathy of undefined significance (MGUS) can precede multiple myeloma, a pr...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0814732a76e2415f9917f09397acc14f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0814732a76e2415f9917f09397acc14f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0814732a76e2415f9917f09397acc14f2021-12-02T08:36:33ZThe potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia1177-54751177-5491https://doaj.org/article/0814732a76e2415f9917f09397acc14f2008-03-01T00:00:00Zhttp://www.dovepress.com/the-potential-role-of-curcumin-diferuloylmethane-in-plasma-cell-dyscra-a65https://doaj.org/toc/1177-5475https://doaj.org/toc/1177-5491Terry Golombick, Terry DiamondDepartment of Endocrinology, St George Hospital, Kogarah, AustraliaAbstract: Plasma cell dyscrasias, most commonly associated with paraproteinemia, are a diverse group of diseases. Monoclonal gammopathy of undefined significance (MGUS) can precede multiple myeloma, a progressive neoplastic disease. MGUS occurs in association with a variety of other diseases and currently no treatment is recommended but rather “watchful waiting”. Given that the size of the M-protein is a risk factor for disease progression, early intervention with the aim of reducing the paraprotein load would provide an innovative therapeutic tool. Preliminary results from our pilot study show a drop of between 5% and 30% serum paraprotein in patients taking curcumin compared with patients on placebo. Curcumin is a diferuloylmethane present in extracts of the rhizome of the Curcuma longa plant. As a natural product, this has exciting potential in the treatment of plasma cell dyscrasias.Keywords: plasma cell dyscrasias, MGUS, myeloma, curcumin, paraproteinemia Terry GolombickTerry DiamondDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2008, Iss Issue 1, Pp 161-163 (2008) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Terry Golombick Terry Diamond The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia |
description |
Terry Golombick, Terry DiamondDepartment of Endocrinology, St George Hospital, Kogarah, AustraliaAbstract: Plasma cell dyscrasias, most commonly associated with paraproteinemia, are a diverse group of diseases. Monoclonal gammopathy of undefined significance (MGUS) can precede multiple myeloma, a progressive neoplastic disease. MGUS occurs in association with a variety of other diseases and currently no treatment is recommended but rather “watchful waiting”. Given that the size of the M-protein is a risk factor for disease progression, early intervention with the aim of reducing the paraprotein load would provide an innovative therapeutic tool. Preliminary results from our pilot study show a drop of between 5% and 30% serum paraprotein in patients taking curcumin compared with patients on placebo. Curcumin is a diferuloylmethane present in extracts of the rhizome of the Curcuma longa plant. As a natural product, this has exciting potential in the treatment of plasma cell dyscrasias.Keywords: plasma cell dyscrasias, MGUS, myeloma, curcumin, paraproteinemia |
format |
article |
author |
Terry Golombick Terry Diamond |
author_facet |
Terry Golombick Terry Diamond |
author_sort |
Terry Golombick |
title |
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia |
title_short |
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia |
title_full |
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia |
title_fullStr |
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia |
title_full_unstemmed |
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia |
title_sort |
potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia |
publisher |
Dove Medical Press |
publishDate |
2008 |
url |
https://doaj.org/article/0814732a76e2415f9917f09397acc14f |
work_keys_str_mv |
AT terrygolombick thepotentialroleofcurcumindiferuloylmethaneinplasmacelldyscrasiasparaproteinemia AT terrydiamond thepotentialroleofcurcumindiferuloylmethaneinplasmacelldyscrasiasparaproteinemia AT terrygolombick potentialroleofcurcumindiferuloylmethaneinplasmacelldyscrasiasparaproteinemia AT terrydiamond potentialroleofcurcumindiferuloylmethaneinplasmacelldyscrasiasparaproteinemia |
_version_ |
1718398445723582464 |